{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:48:32Z","timestamp":1785786512358,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08031-y","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:07:59Z","timestamp":1775149679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychiatric symptoms as clinical warning signals of adult anti-LGI-1 encephalitis: an observational cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yujie","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiye","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"8031_CR1","doi-asserted-by":"crossref","unstructured":"Bastiaansen AEM, et al. Autoimmune encephalitis resembling dementia syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(5).","DOI":"10.1212\/NXI.0000000000001039"},{"key":"8031_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.comppsych.2016.12.006","volume":"74","author":"Q Hao","year":"2017","unstructured":"Hao Q, et al. Clinical characterization of autoimmune encephalitis and psychosis. Compr Psychiatry. 2017;74:9\u201314.","journal-title":"Compr Psychiatry"},{"issue":"14","key":"8031_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87(14):1449\u201356.","journal-title":"Neurology"},{"issue":"4","key":"8031_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"2","key":"8031_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","volume":"122","author":"H Reiber","year":"1994","unstructured":"Reiber H. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122(2):189\u2013203.","journal-title":"J Neurol Sci"},{"issue":"3","key":"8031_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ana.25421","volume":"85","author":"JA Lim","year":"2019","unstructured":"Lim JA, et al. Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol. 2019;85(3):352\u20138.","journal-title":"Ann Neurol"},{"issue":"5","key":"8031_CR7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/acn3.51540","volume":"9","author":"ST Lee","year":"2022","unstructured":"Lee ST, et al. The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis. Ann Clin Transl Neurol. 2022;9(5):610\u201321.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"8031_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nrn.2015.27","volume":"17","author":"SJ Crisp","year":"2016","unstructured":"Crisp SJ, Kullmann DM, Vincent A. Autoimmune synaptopathies Nat Rev Neurosci. 2016;17(2):103\u201317.","journal-title":"Autoimmune synaptopathies Nat Rev Neurosci"},{"issue":"5","key":"8031_CR9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00406-023-01606-w","volume":"274","author":"Y Jia","year":"2024","unstructured":"Jia Y, et al. Psychiatric features in NMDAR and LGI1 antibody-associated autoimmune encephalitis. Eur Arch Psychiatry Clin Neurosci. 2024;274(5):1051\u201361.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"8031_CR10","doi-asserted-by":"publisher","first-page":"674368","DOI":"10.3389\/fneur.2021.674368","volume":"12","author":"TR Li","year":"2021","unstructured":"Li TR, et al. Clinical Characteristics and Long-Term Prognosis of Anti-LGI1 Encephalitis: A Single-Center Cohort Study in Beijing, China. Front Neurol. 2021;12:674368.","journal-title":"Front Neurol"},{"issue":"3","key":"8031_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1474-4422(23)00463-5","volume":"23","author":"A Mu\u00f1oz-Lopetegi","year":"2024","unstructured":"Mu\u00f1oz-Lopetegi A, et al. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study. Lancet Neurol. 2024;23(3):256\u201366.","journal-title":"Lancet Neurol"},{"issue":"6","key":"8031_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/schbul\/sbae155","volume":"50","author":"JH Zhang","year":"2024","unstructured":"Zhang JH, et al. Anti-LGI1 Antibody-Associated Encephalitis Misdiagnosed as Schizophrenia: A Case Report. Schizophr Bull. 2024;50(6):1273\u20136.","journal-title":"Schizophr Bull"},{"issue":"5","key":"8031_CR13","doi-asserted-by":"publisher","first-page":"e70414","DOI":"10.1111\/cns.70414","volume":"31","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, et al. Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti-LGI1 Antibody Encephalitis: A Multicenter Cohort Study. CNS Neurosci Ther. 2025;31(5):e70414.","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"8031_CR14","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/hbm.23197","volume":"37","author":"S Lefebvre","year":"2016","unstructured":"Lefebvre S, et al. Network dynamics during the different stages of hallucinations in schizophrenia. Hum Brain Mapp. 2016;37(7):2571\u201386.","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"8031_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018;141(2):348\u201356.","journal-title":"Brain"},{"issue":"7","key":"8031_CR16","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/brain\/awac116","volume":"145","author":"MM van der Knoop","year":"2022","unstructured":"van der Knoop MM, et al. Biallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy. Brain. 2022;145(7):2301\u201312.","journal-title":"Brain"},{"issue":"3","key":"8031_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1212\/CON.0000000000001089","volume":"28","author":"GS Day","year":"2022","unstructured":"Day GS. Rapidly Progressive Dementia. Continuum (Minneap Minn). 2022;28(3):901\u201336.","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"8031_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","volume":"7","author":"TA Pollak","year":"2020","unstructured":"Pollak TA, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020;7(1):93\u2013108.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"8031_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/imm.12795","volume":"152","author":"AAJ Al-Diwani","year":"2017","unstructured":"Al-Diwani AAJ, et al. Psychosis: an autoimmune disease? Immunology. 2017;152(3):388\u2013401.","journal-title":"Immunology"},{"issue":"5","key":"8031_CR20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","volume":"69","author":"SR Irani","year":"2011","unstructured":"Irani SR, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69(5):892\u2013900.","journal-title":"Ann Neurol"},{"issue":"2","key":"8031_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1192\/bjo.2018.8","volume":"4","author":"JG Scott","year":"2018","unstructured":"Scott JG, et al. The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis. BJPsych Open. 2018;4(2):69\u201374.","journal-title":"BJPsych Open"},{"key":"8031_CR22","doi-asserted-by":"publisher","first-page":"791014","DOI":"10.3389\/fneur.2021.791014","volume":"12","author":"Y Teng","year":"2021","unstructured":"Teng Y, et al. Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review. Front Neurol. 2021;12:791014.","journal-title":"Front Neurol"},{"key":"8031_CR23","doi-asserted-by":"publisher","first-page":"1168302","DOI":"10.3389\/fpsyt.2023.1168302","volume":"14","author":"F Porpiglia","year":"2023","unstructured":"Porpiglia F, et al. Anti-leucine-rich glioma-inactivated 1 encephalitis revealed by a manic episode: insights from frontal lobe dysfunction in neuropsychiatry through neuropsychology and metabolic imaging. A case report. Front Psychiatry. 2023;14:1168302.","journal-title":"Front Psychiatry"},{"key":"8031_CR24","doi-asserted-by":"publisher","first-page":"106542","DOI":"10.1016\/j.clineuro.2021.106542","volume":"203","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, et al. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China. Clin Neurol Neurosurg. 2021;203:106542.","journal-title":"Clin Neurol Neurosurg"},{"issue":"25","key":"8031_CR25","first-page":"1947","volume":"100","author":"JM Li","year":"2020","unstructured":"Li JM, et al. [Clinical features and outcomes in relapsing and monophasic patients with anti-leucine-rich glioma-inactivated 1 encephalitis]. Zhonghua Yi Xue Za Zhi. 2020;100(25):1947\u201351.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"10","key":"8031_CR26","doi-asserted-by":"publisher","first-page":"e081911","DOI":"10.1136\/bmjopen-2023-081911","volume":"14","author":"A Decros","year":"2024","unstructured":"Decros A, et al. Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase. BMJ Open. 2024;14(10):e081911.","journal-title":"BMJ Open"},{"issue":"46","key":"8031_CR27","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","volume":"33","author":"T Ohkawa","year":"2013","unstructured":"Ohkawa T, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci. 2013;33(46):18161\u201374.","journal-title":"J Neurosci"},{"issue":"2","key":"8031_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1176\/appi.neuropsych.20120303","volume":"34","author":"X Huang","year":"2022","unstructured":"Huang X, et al. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis. J Neuropsychiatry Clin Neurosci. 2022;34(2):141\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"8031_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-025-03598-x","volume":"22","author":"Z Kovbasyuk","year":"2025","unstructured":"Kovbasyuk Z, et al. Imaging brain inflammation and blood brain barrier permeability in neurological and psychiatric diseases: a review. J Neuroinflammation. 2025;22(1):275.","journal-title":"J Neuroinflammation"},{"key":"8031_CR30","doi-asserted-by":"crossref","unstructured":"Aboseif A, et al. Clinical determinants of longitudinal disability in LGI-1-IgG autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2024;11(1).","DOI":"10.1212\/NXI.0000000000200178"},{"key":"8031_CR31","doi-asserted-by":"crossref","unstructured":"Lehmann-Horn K, et al. Intrathecal B-cell activation in LGI1 antibody encephalitis. Neurol Neuroimmunol Neuroinflamm. 2020;7(2).","DOI":"10.1212\/NXI.0000000000000669"},{"issue":"248","key":"8031_CR32","doi-asserted-by":"publisher","first-page":"248ra106","DOI":"10.1126\/scitranslmed.3008930","volume":"6","author":"A Palanichamy","year":"2014","unstructured":"Palanichamy A, et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med. 2014;6(248):248ra106.","journal-title":"Sci Transl Med"},{"issue":"1","key":"8031_CR33","first-page":"147","volume":"13","author":"M Gastaldi","year":"2016","unstructured":"Gastaldi M, Thouin A, Vincent A. Antibody-Mediated Autoimmune Encephalopathies Immunotherapies Neurother. 2016;13(1):147\u201362.","journal-title":"Antibody-Mediated Autoimmune Encephalopathies Immunotherapies Neurother"},{"issue":"11","key":"8031_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045\u201357.","journal-title":"Lancet Neurol"},{"issue":"1","key":"8031_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12987-022-00392-2","volume":"19","author":"QL Lai","year":"2022","unstructured":"Lai QL, et al. Evaluation of CSF albumin quotient in neuronal surface antibody-associated autoimmune encephalitis. Fluids Barriers CNS. 2022;19(1):93.","journal-title":"Fluids Barriers CNS"},{"key":"8031_CR36","unstructured":"Thaler FS, et al. Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry. Neurol Neuroimmunol Neuroinflamm. 2021;8(6)."},{"issue":"8","key":"8031_CR37","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/acn3.70105","volume":"12","author":"T Ongphichetmetha","year":"2025","unstructured":"Ongphichetmetha T, et al. Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis. Ann Clin Transl Neurol. 2025;12(8):1670\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"8031_CR38","doi-asserted-by":"crossref","unstructured":"Ludewig S, et al. Antibody properties associate with clinical phenotype in LGI1 encephalitis. Cells. 2023;12(2).","DOI":"10.3390\/cells12020282"},{"issue":"7","key":"8031_CR39","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1093\/brain\/awab187","volume":"144","author":"SR Irani","year":"2021","unstructured":"Irani SR, Nath A, Zipp F. The neuroinflammation collection: a vision for expanding neuro-immune crosstalk in Brain. Brain. 2021;144(7):e59.","journal-title":"Brain"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08031-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08031-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:38:13Z","timestamp":1779233893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08031-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8031"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08031-y","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the First Hospital of Shanxi Medical University. (Approved No. of ethic committee: NO.KYLL-2023-158). The study was conducted according to the Helsinki Declaration, and all participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}